Anti-Aging Polypharmacology

Zhiguo Wang earned his PhD in cardiovascular pharmacology from the Department of Pharmacology and Therapeutics at the Faculty of Medicine & Health Sciences, McGill University, Canada. Currently, he holds the positions of Chief Scientist and Professor at the Central Research Laboratories of the First Affiliated Hospital of Jinan University, China, and serves as the President and Chief Scientist of Cachine Pharmaceutical Inc., China. With a prolific academic career, he has authored 156 research articles in esteemed scientific journals, contributed to 7 monographs, and written 18 book chapters. Additionally, he has served as an editor for 1 book published by reputable scientific publishers. His research interests span various domains including cardiovascular disease and pharmacology, molecular pharmacology, epigenetic polypharmacology, longevity, and anti-aging polypharmacology. Notably, Wang is recognized as one of the pioneers in advancing the 'one drug—multiple targets' principle of polypharmacology, a concept elucidated in his earlier research articles and his monograph 'Polypharmacology: Principles and Methodologies'. Furthermore, he introduced the groundbreaking concept of Anti-aging Polypharmacology and advocates for a low-entropy lifestyle to foster healthy aging and longevity.